Mycobacterium vaccae in the treatment of uveitis

Details Mycobacterium vaccae in the treatment of uveitis Mycobacterium vaccae in the treatment of uveitis

A - Human Necessities

61

K

A61K 39/04 (2006.01) A61K 38/16 (2006.01)

Patent

CA 2095854

Use of antigenic or immunoregulatory material derived from Mycobacterium vaccae in the manufacture of a therapeutic agent for treatment of uveitis. The M. vaccae is suitably in the form of dead cells, preferably billed by autoclaving. The therapeutic agent preferably contains, per dose, antigenic or immunoregulatory material from 10 7 to 10 10 M. vaccae microorganisms.

Affiliated with

Also associated with

Rating

Mycobacterium vaccae in the treatment of uveitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mycobacterium vaccae in the treatment of uveitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycobacterium vaccae in the treatment of uveitis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1365584